Transaction in Own Shares

Summary by AI BETAClose X

RTW Biotech Opportunities Ltd announced a share buyback on December 9, 2025, repurchasing 250,000 ordinary shares at $1.94 per share. Following this transaction, the company's issued ordinary share capital stands at 345,967,440, with 19,593,791 shares held in treasury, resulting in a total of 326,373,649 voting rights. This buyback was authorized by shareholders at the June 2025 Annual General Meeting, allowing for repurchases up to 14.99% of outstanding shares, and the company intends to hold repurchased shares in treasury.

Disclaimer*

UK 100

Latest directors dealings